Close
Listen

Aims

We aim to:

  • Determine the value of technology in people with (pre)diabetes;
  • Elucidate the role of innate immunity in the pathophysiology of long-term micro- and macrovascular complications and explore the benefit of anti-inflammatory interventions;
  • Disentangle the relationship of obesity with the immune system, predisposing to the development of (pre)diabetes, and study the effect of (non)-pharmacologically-induced weight loss.


go to main content
Research Research groups Internal medicine in particular diabetology

About Internal medicine in particular diabetology

We aim to characterize the underlying mechanisms that drive the development of (pre)diabetes and its complications and to develop appropriate care by including technological innovations resulting in a personalized approach to reverse the negative impact of (pre)diabetes.

Research group leader

prof. dr. Cees Tack

contact form

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more
Close
Listen

Publications

See the publication list of the research group leader on Web of Science.


Internationally we are also known as

The impacts of (pre)diabetes

Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.